(1)
Effects of the CB1 Receptor Antagonists AM6545 and AM4113 on Metabolic Syndrome-Induced Prostatic Hyperplasia in Rats. Biomol Biomed 2023, 23 (6), 1069–1078. https://doi.org/10.17305/bb.2023.9173.